Hepatic amyloidosis: a prevalence study and clinical characterization of a rare and severe disease.

Emanuel DiasHélder CardosoMargarida MarquesRodrigo LiberalSusana LopesPedro PereiraJoão Santos-AntunesJorge PinheiroJoanne LopesFátima CarneiroGuilherme Macedo

Published in: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva (2022)

We report a low prevalence (0.4%) of amyloidosis among patients undergoing liver biopsy. Although rare, hepatic amyloidosis is associated with a dismal prognosis and a high index of suspicion is crucial to achieve an early diagnosis.

Keyphrases

patients undergoing
risk factors
multiple myeloma
early onset
drug induced